Nose-to-Brain Delivery of Nanoformulations for Treatment of Depression: Focus on Antioxidant and Anti-Inflammatory Pathways

Depression is commonly linked to heightened levels of pro-inflammatory markers, emphasizing the importance of addressing this aspect for effective treatment. Current treatment options encompass selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), and bioactive compounds from herbal medicine with Read More …